Robust

In August 2026, Robust’s mix concentrated further in Flower at 61.5% share, but that anchor shrank with Flower down 24.23% year over year and 18.01% month over month, pulling total brand sales down 8.99% YoY even as average price fell 5.31%. Offsetting momentum came from smaller buckets: Concentrates rose 37.22% YoY despite a 16.48% MoM dip, Vapor Pens climbed 31.65% YoY while sliding 19.51% MoM, and Pre-Roll increased 13.55% YoY but dropped 20.34% MoM; Capsules were the only category with sequential stability at +0.36% MoM and the fastest annual growth at 65.18%. With Missouri Flower ranked 23 and Flower still the majority share, the pattern implies an overexposure to a declining core while faster-growing, lower-share formats struggle to offset short-term pullbacks, indicating a rebalancing opportunity toward higher-growth segments.

The divergent trend—majority-share Flower contracting double digits while Capsules and Concentrates expand 65.18% and 37.22% YoY respectively—suggests Robust’s positioning is skewed toward value-sensitive core shoppers as indicated by a 5.31% YoY price decrease and category-level MoM retrenchment of 16–20% across three inhalable formats. The combination of a 7.27% share in Capsules with positive MoM and the 15.19% share in Concentrates with large YoY gains points to headroom to migrate mix away from the 61.5% Flower exposure while shoring up Vapor Pens at 7.42% share after a 19.51% MoM decline; the implication is that shifting assortment and promotion weight into Capsules and Concentrates can lift rank from 23 in Flower dependence by reducing sensitivity to Flower’s 24.23% YoY decline and 18.01% MoM volatility.